Vanda Pharmaceuticals Inc. (VNDA) financial statements (2021 and earlier)

Company profile

Business Address 2200 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments368312257143141143130
Cash and cash equivalents61456134405161
Short-term investments3072671961101019269
Receivables3026291820164
Inventory, net of allowances, customer advances and progress billings1111115
Inventory1111115
Prepaid expense    253
Other current assets   3200
Other undisclosed current assets101512580 
Total current assets:409354299170174167142
Noncurrent Assets
Inventory, Noncurrent533322 
Operating lease, right-of-use asset10 
Property, plant and equipment4445552
Intangible assets, net (including goodwill)22232526283927
Intangible assets, net (excluding goodwill)22232526283927
Restricted cash and investments      1
Deferred income tax assets82 
Other noncurrent assets      0
Other undisclosed noncurrent assets21001111 
Total noncurrent assets:1241303336364730
TOTAL ASSETS:533484332205210213172
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3228222016168
Accounts payable      1
Accrued liabilities121310109127
Employee-related liabilities11765400
Other undisclosed accounts payable and accrued liabilities986533 
Deferred revenue and credits   0
Other liabilities      0
Other undisclosed current liabilities343231503436(0)
Total current liabilities:6660537050518
Noncurrent Liabilities
Long-term debt and lease obligation11      
Operating lease, liability11 
Liabilities, other than long-term debt3144443
Deferred revenue and credits   3
Other liabilities314444 
Other undisclosed noncurrent liabilities 12  2525 
Total noncurrent liabilities:14134429293
Total liabilities:80735774798011
Stockholders' equity
Stockholders' equity attributable to parent453411275131131133161
Common stock0000000
Additional paid in capital650631612493477461449
Accumulated other comprehensive income (loss)000(0)000
Accumulated deficit(197)(221)(336)(361)(346)(328)(288)
Total stockholders' equity:453411275131131133161
TOTAL LIABILITIES AND EQUITY:533484332205210213172

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues24822719316514611050
Revenue, net16514611050
Cost of revenue(23)(24)(21)(18)(25)(23)(2)
Cost of goods and services sold(23)    (23)(2)
Gross profit:2252031731471218649
Operating expenses(198)(180)(151)(164)(140)(127)(29)
Operating income (loss):272322(17)(19)(40)20
Nonoperating expense
(Investment Income, Nonoperating)
      (0)
Other undisclosed income from continuing operations before equity method investments, income taxes46411  
Income (loss) from continuing operations before income taxes:322925(15)(18)(40)20
Income tax expense (benefit)(8)87(0)(0)(0)  
Net income (loss):2311625(16)(18)(40)20
Other undisclosed net income attributable to parent     00
Net income (loss) available to common stockholders, diluted:2311625(16)(18)(40)20

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):2311625(16)(18)(40)20
Other comprehensive income (loss)(0)00(0)00(0)
Comprehensive income (loss):2311625(16)(18)(40)20
Other undisclosed comprehensive income, net of tax, attributable to parent     00
Comprehensive income (loss), net of tax, attributable to parent:2311625(16)(18)(40)20

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: